UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 30

Sortiert nach

An Inducible Lentiviral Guide RNA Platform Enables the Identification of Tumor-Essential Genes and Tumor-Promoting Mutations In Vivo

Cell reports (Cambridge), 2015-03, Vol.10 (8), p.1422-1432

2015

Link zum Volltext

Verfügbarkeit prüfen

Loss of a Single Mcl-1 Allele Inhibits MYC-Driven Lymphomagenesis by Sensitizing Pro-B Cells to Apoptosis

Cell reports (Cambridge), 2016-03, Vol.14 (10), p.2337-2347

2016

Link zum Volltext

Verfügbarkeit prüfen

Therapeutic Response to Non-genotoxic Activation of p53 by Nutlin3a Is Driven by PUMA-Mediated Apoptosis in Lymphoma Cells

Cell reports (Cambridge), 2016-03, Vol.14 (8), p.1858-1866

2016

Link zum Volltext

Verfügbarkeit prüfen

Tumor-Suppressor Functions of the TP53 Pathway

Cold Spring Harbor perspectives in medicine, 2016-05, Vol.6 (5), p.a026062

2016

Link zum Volltext

Verfügbarkeit prüfen

RAG-induced DNA lesions activate proapoptotic BIM to suppress lymphomagenesis in p53-deficient mice

The Journal of experimental medicine, 2016-09, Vol.213 (10), p.2039-2048

2016

Link zum Volltext

Verfügbarkeit prüfen

Evidence-Based Minireview: Clinical utilization of panel-based molecular testing for patients with AML

Hematology, 2022-12, Vol.2022 (1), p.30

2022

Link zum Volltext

Verfügbarkeit prüfen

SOHO State of the Art and Next Questions: Treatment of Higher-Risk Myelodysplastic Syndromes

Clinical lymphoma, myeloma and leukemia, 2022-12, Vol.22 (12), p.869-877

2022

Link zum Volltext

Verfügbarkeit prüfen

Targeting of MCL-1 kills MYC-driven mouse and human lymphomas even when they bear mutations in p53

Genes & development, 2014-01, Vol.28 (1), p.58-70

2014

Link zum Volltext

Verfügbarkeit prüfen

Mutant TRP53 exerts a target gene-selective dominant-negative effect to drive tumor development

Genes & development, 2018-11, Vol.32 (21-22), p.1420-1429

2018

Link zum Volltext

Verfügbarkeit prüfen

MOZ and Menin-MLL Complexes Are Complementary Regulators of Chromatin Association and Transcriptional Output in Gastrointestinal Stromal Tumor

Cancer discovery, 2022-07, Vol.12 (7), p.1804-1823

2022

Link zum Volltext

Verfügbarkeit prüfen

Potent Ikaros Degradation By the Cereblon E3 Ligase Modulator CC-92480 Is Effective in Combination with Menin-MLL1 Inhibition in MLL1-Rearranged and NPM1-Mutant AML

Blood, 2021-11, Vol.138 (Supplement 1), p.208-208

2021

Link zum Volltext

Verfügbarkeit prüfen

Mutant p53 Enhances the Development and Sustained Growth of MYC-Driven Lymphoma and Exerts a Dominant Negative Effect Preferentially Deregulating Pathways for Metabolism and DNA Repair

Blood, 2016-12, Vol.128 (22), p.1545-1545

2016

Link zum Volltext

Verfügbarkeit prüfen

International trends in incidence of osteosarcoma (1988‐2012)

International journal of cancer, 2021-09, Vol.149 (5), p.1044-1053

2021

Link zum Volltext

Verfügbarkeit prüfen

Comparative international incidence of Ewing sarcoma 1988 to 2012

International journal of cancer, 2021-09, Vol.149 (5), p.1054-1066

2021

Link zum Volltext

Verfügbarkeit prüfen

The Lessons Will Be Televised: Examining Television Portrayals of Sexual Consequences by Gender

Journalism & mass communication quarterly, 2023-03, Vol.100 (1), p.172-192

2023

Link zum Volltext

Verfügbarkeit prüfen

New Food Crop Domestication in the Age of Gene Editing: Genetic, Agronomic and Cultural Change Remain Co-evolutionarily Entangled

Frontiers in plant science, 2020-06, Vol.11, p.789-789

2020

Link zum Volltext

Verfügbarkeit prüfen

Protocol for multiplex fluorescent immunohistochemistry in free-floating rodent brain tissues

STAR protocols, 2022-12, Vol.3 (4), p.101672-101672, Article 101672

2022

Link zum Volltext

Verfügbarkeit prüfen

Species-typical group size differentially influences social reward neural circuitry during nonreproductive social interactions

iScience, 2022-05, Vol.25 (5), p.104230-104230, Article 104230

2022

Link zum Volltext

Verfügbarkeit prüfen

MP29-15 REMOTELY-MONITORED SLEEP MEASURES IN PROSTATE CANCER PATIENTS UNDERGOING ANDROGEN DEPRIVATION THERAPY (ADT)

The Journal of urology, 2023-04, Vol.209 (Supplement 4)

2023

Link zum Volltext

Verfügbarkeit prüfen

Advancing the Sustainable Development Goals through improving eye health: a scoping review

The Lancet. Planetary health, 2022-03, Vol.6 (3), p.e270-e280

2022

Link zum Volltext

Verfügbarkeit prüfen

Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study

The lancet. Diabetes & endocrinology, 2019-12, Vol.7 (12), p.899-911

2019

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 30

Suche als RSS-Feed

Aktive Filter

KollektionNature Journals Online

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(29)
Mit Volltextzugriff
(27)

Publikationsform

Artikel
(30)

Sprache

Englisch
(30)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(24)
Life Sciences & Biomedicine
(22)
Humans
(15)
Animals
(11)
Mice
(8)
Mice, Inbred C57bl
(7)
Cell Biology
(6)
Oncology
(6)
Tumor Suppressor Protein P53 - Metabolism
(6)
Female
(5)
Tumor Suppressor Protein P53 - Genetics
(5)
Aged
(4)
Hematology
(4)
Lymphoma - Pathology
(4)
Mice, Knockout
(4)
Mice, Transgenic
(4)
Mutation
(4)
Adult
(3)
Apoptosis
(3)
Apoptosis Regulatory Proteins - Genetics
(3)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

An Inducible Lentiviral Guide RNA Platform Enables the Identification of Tumor-Essential Genes and Tumor-Promoting Mutations In Vivo

Loss of a Single Mcl-1 Allele Inhibits MYC-Driven Lymphomagenesis by Sensitizing Pro-B Cells to Apoptosis

Therapeutic Response to Non-genotoxic Activation of p53 by Nutlin3a Is Driven by PUMA-Mediated Apoptosis in Lymphoma Cells

Tumor-Suppressor Functions of the TP53 Pathway

RAG-induced DNA lesions activate proapoptotic BIM to suppress lymphomagenesis in p53-deficient mice

Evidence-Based Minireview: Clinical utilization of panel-based molecular testing for patients with AML

SOHO State of the Art and Next Questions: Treatment of Higher-Risk Myelodysplastic Syndromes

Intact TP-53 function is essential for sustaining durable responses to BH3-mimetic drugs in leukemias

Targeting of MCL-1 kills MYC-driven mouse and human lymphomas even when they bear mutations in p53

Mezigdomide is effective alone and in combination with menin inhibition in preclinical models of KMT2A-r and NPM1c AML

Mutant TRP53 exerts a target gene-selective dominant-negative effect to drive tumor development

MOZ and Menin-MLL Complexes Are Complementary Regulators of Chromatin Association and Transcriptional Output in Gastrointestinal Stromal Tumor

PHF6 regulates hematopoietic stem and progenitor cells and its loss synergizes with expression of TLX3 to cause leukemia

Potent Ikaros Degradation By the Cereblon E3 Ligase Modulator CC-92480 Is Effective in Combination with Menin-MLL1 Inhibition in MLL1-Rearranged and NPM1-Mutant AML

Mutant p53 Enhances the Development and Sustained Growth of MYC-Driven Lymphoma and Exerts a Dominant Negative Effect Preferentially Deregulating Pathways for Metabolism and DNA Repair

International trends in incidence of osteosarcoma (1988‐2012)

Comparative international incidence of Ewing sarcoma 1988 to 2012

The Lessons Will Be Televised: Examining Television Portrayals of Sexual Consequences by Gender

New Food Crop Domestication in the Age of Gene Editing: Genetic, Agronomic and Cultural Change Remain Co-evolutionarily Entangled

Protocol for multiplex fluorescent immunohistochemistry in free-floating rodent brain tissues

Species-typical group size differentially influences social reward neural circuitry during nonreproductive social interactions

MP29-15 REMOTELY-MONITORED SLEEP MEASURES IN PROSTATE CANCER PATIENTS UNDERGOING ANDROGEN DEPRIVATION THERAPY (ADT)

Patient reported dry mouth: Instrument comparison and model performance for correlation with quality of life in head and neck cancer survivors

Advancing the Sustainable Development Goals through improving eye health: a scoping review

Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study

Aktive Filter

Suchergebnisse filtern